DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc., based in Hopkins, MN, is dedicated to developing innovative therapies aimed at improving the lives of individuals facing serious vascular diseases, with a primary focus on preeclampsia and acute ischemic stroke. The company's approach centers on enhancing blood flow to ischemic tissues, thereby advancing patient outcomes in these critical areas.

With a significant unmet need for effective treatment options, DiaMedica is investigating its investigational drug candidate DM199, which aims to restore normal levels of the KLK1 protein to help regulate blood flow and maintain vascular homeostasis. The company is addressing alarming trends in maternal mortality related to preeclampsia and the urgent requirements for stroke patients, contributing meaningfully to these challenging health issues.

Generated from the website